Nyxoah SA (EBR:NYXH)
Belgium · Delayed Price · Currency is EUR 0.7900
-0.0390 (-4.70%)
At close: Oct 30, 2026
Nyxoah Market Cap
Nyxoah has a market cap or net worth of €79.06 million as of October 30, 2026. It is the 25,846th most valuable company in the world and the 82nd biggest in Belgium. Its market cap has decreased by 52.79% in one year.
Market Cap
79.06M
Enterprise Value
41.26M
Revenue
21.66M
Global Rank
Country Rank
#82 Belgium
PE Ratio
n/a
ChartMarket Cap Chart
Since September 18, 2020, Nyxoah's market cap has decreased from 417.77M to 79.06M, a decrease of -81.08%. That is a compound annual growth rate of -23.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 79.06M | -55.02% |
| Dec 31, 2025 | 175.76M | -43.15% |
| Dec 31, 2024 | 309.15M | 153.09% |
| Dec 29, 2023 | 122.15M | -8.05% |
| Dec 30, 2022 | 132.85M | -72.29% |
| Dec 31, 2021 | 479.37M | 37.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 51.23B |
| argenx SE | 48.95B |
| Financière de Tubize | 9.79B |
| Fagron NV | 1.73B |
| Ion Beam Applications | 475.30M |
| Onward Medical | 157.14M |
| Hyloris Pharmaceuticals | 102.20M |
| Sequana Medical NV | 43.56M |